<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38019841</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>11</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e0250909</StartPage><MedlinePgn>e0250909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0250909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0250909</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent symptoms are reported in patients who survive the initial stage of COVID-19, often referred to as "long COVID" or "post-acute sequelae of SARS-CoV-2 infection" (PASC); however, evidence on their incidence is still lacking, and symptoms relevant to pain are yet to be assessed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search was performed using the electronic databases PubMed, EMBASE, Scopus, and CHINAL and preprint servers MedR&#x3c7;iv and BioR&#x3c7;iv through January 15, 2021. The primary outcome was pain-related symptoms such as headache or myalgia. Secondary outcomes were symptoms relevant to pain (depression or muscle weakness) and symptoms frequently reported (anosmia and dyspnea). Incidence rates of symptoms were pooled using inverse variance methods with a DerSimonian-Laird random-effects model. The source of heterogeneity was explored using meta-regression, with follow-up period, age and sex as covariates.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 38 studies including 19,460 patients were eligible. Eight pain-related symptoms and 26 other symptoms were identified. The highest pooled incidence among pain-related symptoms was chest pain (17%, 95% confidence interval [CI], 11%-24%), followed by headache (16%, 95% CI, 9%-27%), arthralgia (13%, 95% CI, 7%-24%), neuralgia (12%, 95% CI, 3%-38%) and abdominal pain (11%, 95% CI, 7%-16%). The highest pooled incidence among other symptoms was fatigue (44%, 95% CI, 32%-57%), followed by insomnia (27%, 95% CI, 10%-55%), dyspnea (26%, 95% CI, 17%-38%), weakness (25%, 95% CI, 8%-56%) and anosmia (19%, 95% CI, 13%-27%). Substantial heterogeneity was identified (I2, 50-100%). Meta-regression analyses partially accounted for the source of heterogeneity, and yet, 53% of the symptoms remained unexplained.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The current meta-analysis may provide a complete picture of incidence in PASC. It remains unclear, however, whether post-COVID symptoms progress or regress over time or to what extent PASC are associated with age or sex.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Hoshijima et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoshijima</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-1466-6228</Identifier><AffiliationInfo><Affiliation>Division of Dento-oral Anesthesiology, Tohoku University Graduate School of Dentistry, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihara</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seki</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5311-5088</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyuga</LastName><ForeName>Shunsuke</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1095-8066</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuratani</LastName><ForeName>Norifumi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-1508-7228</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Saitama Children's Medical Center, Saitama, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiga</LastName><ForeName>Toshiya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0347-7181</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Pain Medicine, International University of Health and Welfare Ichikawa Hospital, Ichikawa, Chiba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006261" MajorTopicYN="N">Headache</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38019841</ArticleId><ArticleId IdType="pmc">PMC10686440</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0250909</ArticleId><ArticleId IdType="pii">PONE-D-21-13798</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lancet The. Facing up to long COVID. Lancet. 2020; 396(10266): 1861. doi: 10.1016/s0140-6736(20)32662-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al.. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020; 20(10): 1115&#x2013;1117. doi: 10.1016/s1473-3099(20)30701-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: What do we know about "long covid"? BMJ. 2020; 370: m2815. doi: 10.1136/bmj.m2815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2815</ArticleId><ArticleId IdType="pubmed">32665317</ArticleId></ArticleIdList></Reference><Reference><Citation>Long COVID: let patients help define long-lasting COVID symptoms. Nature. 2020; 586(7828): 170. doi: 10.1038/d41586-020-02796-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021; 268: 113426. 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al.. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020; 111(1): 10&#x2013;12. doi: 10.7196/SAMJ.2020.v111i11.15433</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institutes of Health. NIH launches new initiative to study &#x201c;Long COVID&#x201d;. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid. Accessed April 18, 2021.</Citation></Reference><Reference><Citation>Su S, Cui H, Wang T, Shen X, Ma C. Pain: A potential new label of COVID-19. Brain Behav Immun. 2020; 87: 159&#x2013;160. 10.1016/j.bbi.2020.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.025</ArticleId><ArticleId IdType="pmc">PMC7204693</ArticleId><ArticleId IdType="pubmed">32389704</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Brit J Anaesth. 2020; 125(4): 436&#x2013;440. doi: 10.1016/j.bja.2020.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC. Outcomes for patients following hospitalization for COVID-19. JAMA. 2021; 325(15): 1511&#x2013;1512. doi: 10.1001/jama.2021.3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.3430</ArticleId><ArticleId IdType="pubmed">33729429</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares FHC, Kubota GT, Fernandes AM, Hojo B, Couras C, Costa BV, et al.. Prevalence and characteristics of new-onset pain in COVID-19 survivors, a controlled study. Eur J Pain. 2021: doi: 10.1002/ejp.1755</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1755</ArticleId><ArticleId IdType="pmc">PMC8013219</ArticleId><ArticleId IdType="pubmed">33619793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokugamage AU, Bowen MA, Blair J. Long covid: doctors must assess and investigate patients properly. BMJ. 2020; 371: m4583. doi: 10.1136/bmj.m4583</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4583</ArticleId><ArticleId IdType="pubmed">33268328</ArticleId></ArticleIdList></Reference><Reference><Citation>PRISMA: transparent reporting of systematic reviews and meta-analyses. http://www.prisma-statement.org/PRISMAStatement/ Accessed April 28, 2021.</Citation></Reference><Reference><Citation>Wells GA, Shea B,O&#x2019;Connell D, Welch V, Losos M, Tugwell P. The Newcastle&#x2013;Ottawa scale(NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed April 18, 2021.</Citation></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013; 67(11): 974&#x2013;978. doi: 10.1136/jech-2013-203104</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3): 177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JT, Rothstein HR, eds. Introduction to meta-analysis. West Sussex, UK: John Wiley and Sons, Ltd.; 2009.</Citation></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109): 629&#x2013;634. doi: 10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al.. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: Results from a prospective UK cohort. Thorax. 2020; 76(4): 399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Borsetto D, Fabbris C, Spinato G, Frezza D, Menegaldo A, et al.. Evolution of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Head Neck Surg. 2020; 146(8): 729&#x2013;732. doi: 10.1001/jamaoto.2020.1379</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoto.2020.1379</ArticleId><ArticleId IdType="pmc">PMC7333173</ArticleId><ArticleId IdType="pubmed">32614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA 2020; 324(6): 603&#x2013;605. doi: 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al.. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2020; 27(2): 258&#x2013;263. doi: 10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D, Calderwood C, Skyllberg E, Ainley A. Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis. BMJ Open Respir Res. 2021; 8(1): e000813. doi: 10.1136/bmjresp-2020-000813</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000813</ArticleId><ArticleId IdType="pmc">PMC7976675</ArticleId><ArticleId IdType="pubmed">33731329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiesa-Estomba CM, Lechien JR, Radulesco T, Michel J, Sowerby LJ, Hopkins C, et al.. Patterns of smell recovery in 751 patients affected by the COVID-19 outbreak. Eur J Neurol. 2020; 27(11): 2318&#x2013;2321. doi: 10.1111/ene.14440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14440</ArticleId><ArticleId IdType="pmc">PMC7405216</ArticleId><ArticleId IdType="pubmed">32677329</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, et al.. Long-term COVID-19 symptoms in a large unselected population. medRxiv. 2020: 2020.10.07. doi: 10.1101/2020.10.07.20208702</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020: 2020.12.24. doi: 10.1101/2020.12.24.20248802</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.24.20248802</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Kapur S, Alberts J, Badley AD, Deckeret GA, et al.. Multi-organ impairment in low-risk individuals with long COVID. medRxiv. 2020: 2020.10.14.20212555. doi: 10.1101/2020.10.14.20212555</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.14.20212555</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro-Perez M, Martin-Garcia A, Almeida J, Villacorta E, Perez-Pons A, et al.. Pericarditis and myocarditis long after SARS-CoV-2 infection: a cross-sectional descriptive study in health-care workers. medRxiv. 2020: 2020.07.12. doi: 10.1101/2020.07.12.20151316</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.12.20151316</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC, et al.. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020; 6(4): 00542&#x2013;2020. doi: 10.1183/23120541.00542&#x2013;2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542&#x2013;2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al.. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021; 93(2): 1013&#x2013;1022. doi: 10.1002/jmv.26368</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270): 220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H, Asseo K, Karni N, Benjamini Y, Nir-Paz R, Muszkat M, et al.. Onset, duration, and persistence of taste and smell changes and other COVID-19 symptoms: longitudinal study in Israeli patients. medRxiv. 2020: 2020.09.25.20201343. doi: 10.1101/2020.09.25.20201343</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.25.20201343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovato A, Galletti C, Galletti B, de Filippis C. Clinical characteristics associated with persistent olfactory and taste alterations in COVID-19: a preliminary report on 121 patients. Am J Otolaryngol. 2020; 41(5): 102548. doi: 10.1016/j.amjoto.2020.102548</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102548</ArticleId><ArticleId IdType="pmc">PMC7250081</ArticleId><ArticleId IdType="pubmed">32516656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al.. &#x2019;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020. doi: 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradian ST, Parandeh A, Khalili R, Karimi L. Delayed symptoms in patients recovered from COVID-19. Iran J Public Health. 2020; 49(11): 2120&#x2013;2127. doi: 10.18502/ijph.v49i11.4729</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijph.v49i11.4729</ArticleId><ArticleId IdType="pmc">PMC7917497</ArticleId><ArticleId IdType="pubmed">33708732</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand&#xe3;o Neto D, Fornazieri MA, Dib C, Di Francesco RC, Doty RL, Voegels RL, et al.. Chemosensory dysfunction in COVID-19: prevalences, recovery rates, and clinical associations on a large Brazilian sample. Otolaryngol Head Neck Surg 2021; 164(3): 512&#x2013;518. doi: 10.1177/0194599820954825</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820954825</ArticleId><ArticleId IdType="pmc">PMC7464054</ArticleId><ArticleId IdType="pubmed">32867582</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, &#xc1; Steig B, Gaini S, et al.. Long COVID in the Faroe Islands:-a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020: ciaa1792. doi: 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Piccinelli SC, Zoppi N, Bonzi G, Sattin D, et al.. COVID-19 severity impacts on long-term neurological manifestation after hospitalisation. medRxiv. 2021: 2020.12.27. doi: 10.1101/2020.12.27.20248903</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.12.27.20248903</ArticleId></ArticleIdList></Reference><Reference><Citation>Poncet-Megemont L, Paris P, Tronchere A, Salazard JP, Pereira B, Dallel R, et al.. High prevalence of headaches during Covid-19 infection: a retrospective cohort study. Headache. 2020; 60(10): 2578&#x2013;2582. doi: 10.1111/head.13923</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13923</ArticleId><ArticleId IdType="pmc">PMC7436456</ArticleId><ArticleId IdType="pubmed">32757419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani H, Davoudi-Monfared E, Nourian A, Nabiee M, Sadeghi S, Khalili H, et al.. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir. Daru. 2020; 28(2): 625&#x2013;634. doi: 10.1007/s40199-020-00369-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40199-020-00369-2</ArticleId><ArticleId IdType="pmc">PMC7453126</ArticleId><ArticleId IdType="pubmed">32857301</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D, Slama D, De Broucker T, Karmochkine M, Pavie J, Sorbets E, et al.. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2020; 82(2): e1&#x2013;e4. doi: 10.1016/j.jinf.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj JPJ, Burkett AB, Hinds SN, Paz AS, Assing A, Juneja S, et al.. Three-month outcomes in hospitalized COVID-19 patients. medRxiv. 2020: 2020.10.16. doi: 10.1101/2020.10.16.20211029</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.16.20211029</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020; thoraxjnl-2020&#x2013;216377. doi: 10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al.. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. 2020: 2020.10.19.20214494. doi: 10.1101/2020.10.19.20214494</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al.. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(30): 993&#x2013;998. doi: 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Bai F, Castoldi R, Barbanotti D, Falcinella C, Mul&#xe8; G, et al.. Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy. J Med Virol. 2021; 93(2): 1175&#x2013;1179. doi: 10.1002/jmv.26459</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al.. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020; 15(11): e0240784. doi: 10.1371/journal.pone.024078</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.024078</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Xu H, Jiang H, Wang L, Lu C, Wei X, et al.. Clinical features and outcomes of discharged coronavirus disease 2019 patients: a prospective cohort study. QJM. 2020; 113(9): 657&#x2013;665. doi: 10.1093/qjmed/hcaa178</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa178</ArticleId><ArticleId IdType="pmc">PMC7313792</ArticleId><ArticleId IdType="pubmed">32442308</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerahandi H, Hochman KA, Simon E, Blaum C, Chodosh J, Duan E, et al.. Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med. 2021; 36(3): 738&#x2013;745. doi: 10.1007/s11606-020-06338-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06338-4</ArticleId><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Hu X, Song J, Yang D, Xu J, Cheng K, et al.. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China. Clin Transl Med. 2020; 10(2): e52. doi: 10.1002/ctm2.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.52</ArticleId><ArticleId IdType="pmc">PMC7300592</ArticleId><ArticleId IdType="pubmed">32508037</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al.. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021; 27(1): 89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan N, Wang W, Gao Y, Zhou J, Ye J, Xu Z, et al.. Medium term follow-up of 337 patients with coronavirus disease 2019 (COVID-19) in a Fangcang Shelter Hospital in Wuhan, China. Front Med (Lausanne). 2020; 7: 373. doi: 10.3389/fmed.2020.00373</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00373</ArticleId><ArticleId IdType="pmc">PMC7347902</ArticleId><ArticleId IdType="pubmed">32719806</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al.. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. doi: 10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med 2021; 174(4): 576&#x2013;578. doi: 10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al.. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect 2020; 81(6): e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al.. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 2021; 82(3): 378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger JR. COVID-19 and the nervous system. J Neurovirol. 2020; 26(2): 143&#x2013;148. doi: 10.1007/s13365-020-00840-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-020-00840-5</ArticleId><ArticleId IdType="pmc">PMC7245181</ArticleId><ArticleId IdType="pubmed">32447630</ArticleId></ArticleIdList></Reference><Reference><Citation>Niazkar HR, Zibaee B, Nasimi A, Bahri N. The neurological manifestations of COVID-19: a review article. Neurol Sci. 2020; 41(7): 1667&#x2013;1671. doi: 10.1007/s10072-020-04486-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04486-3</ArticleId><ArticleId IdType="pmc">PMC7262683</ArticleId><ArticleId IdType="pubmed">32483687</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, G&#xfc;l A, Baykan B. COVID-19 is a real headache! Headache. 2020; 60(7): 1415&#x2013;1421. doi: 10.1111/head.13856</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13856</ArticleId><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman KJ, Murovska M, Pheby DFH, Zalewski P. Our evolving understanding of ME/CFS. Medicina (Kaunas). 2021; 57(3): 200. doi: 10.3390/medicina57030200</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030200</ArticleId><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bair MJ, Krebs EE. Fibromyalgia. Ann Intern Med. 2020; 172(5): ITC33&#x2013;ITC48. doi: 10.7326/aitc202003030</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/aitc202003030</ArticleId><ArticleId IdType="pubmed">32120395</ArticleId></ArticleIdList></Reference><Reference><Citation>Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al.. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020; 102(14): 1197&#x2013;1204. doi: 10.2106/jbjs.20.00847</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/jbjs.20.00847</ArticleId><ArticleId IdType="pmc">PMC7508274</ArticleId><ArticleId IdType="pubmed">32675661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Navarro-Santana M, Plaza-Manzano G, Palacios-Cena D, Arendt-Nielsen L. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis. Pain 2022;163(7):1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et al.. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect 2022;28(5):657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>